Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells

Arthritis Research and Therapy

Volumn 12, Issue 1, 2010, Pages

  Ghosh, Peter ^a,b   Wu, Jiehua ^a   Shimmon, Susan ^a   Zannettino, Andrew C W ^c   Gronthos, Stan ^c   Itescu, Silviu ^b  

^a Proteobioactives Pty Ltd   (Australia)

^b Mesoblast Limited   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; DEXTRAN SULFATE; DNA; HEPARIN; HYALURONIC ACID; PENTOSAN POLYSULFATE; PROTEOGLYCAN; THYMIDINE; TOLONIUM CHLORIDE; TRITIUM; ANTIINFLAMMATORY AGENT; COLLAGEN;

ADIPOGENESIS; ADULT; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PROTEOGLYCAN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; CARTILAGE CELL; CELL SEPARATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION PROFILING; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTI-INFLAMMATORY AGENTS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CHONDROCYTES; CHONDROGENESIS; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; PENTOSAN SULFURIC POLYESTER; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77949431988     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2935     Document Type: Article

References (52)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147. 10.1126/science.284.5411.143, 10102814.
2. Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 2008, 10:320-330. 10.1080/14653240802217011, 18574765.
3. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008, 10:223. 10.1186/ar2514, 18947375.
4. Spagnoli A, Longobardi L, O'Rear L. Cartilage disorders: potential therapeutic use of mesenchymal stem cells. Endocr Dev 2005, 9:17-30. full_text, 15879685.
5. Jorgensen C, Djouad F, Bouffi C, Mrugala D, Noel D. Multipotent mesenchymal stromal cells in articular diseases. Best Pract Res Clin Rheumatol 2008, 22:269-284. 10.1016/j.berh.2008.01.005, 18455684.
6. Noth U, Steinert AF, Tuan RS. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 2008, 4:371-380.
7. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell based tissue engineering. Arthritis Res Ther 2003, 5:32-45. 10.1186/ar614, 154434, 12716446.
8. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997, 12:1335-1347. 10.1359/jbmr.1997.12.9.1335, 9286749.
9. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003, 116:1827-1835. 10.1242/jcs.00369, 12665563.
10. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000, 113:1161-1166.
11. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 2003, 18:696-704. 10.1359/jbmr.2003.18.4.696, 12674330.
12. Gronthos S, McCarty R, Mrozik K, Fitter S, Paton S, Menicanin D, Itescu S, Bartold PM, Xian C, Zannettino AC. Heat shock protein-90 beta (Hsp90ss) is expressed at the surface of multipotential mesenchymal precursor cells (MPC): generation of a novel monoclonal antibody, STRO-4, with specificity for MPC from human and ovine tissues. Stem Cells Dev 2009, 18:1253-1262. 10.1089/scd.2007.0069, 19327008.
13. Gronthos S, Fitter S, Diamond P, Simmons PJ, Itescu S, Zannettino ACW. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue non-specific alkaline phosphatase expressed by multipotent bone marrow stromal cells. Stem Cells Dev 2007, 16:953-963. 10.1089/scd.2007.0069, 18158854.
14. Miljkovic ND, Cooper GM, Marra KG. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage 2008, 16:1121-1130. 10.1016/j.joca.2008.03.003, 18406633.
15. Watabe T, Miyazono K. Role of TGF-beta family signalling in stem cell renewal and differentiation. Cell Res 2009, 19:103-115. 10.1038/cr.2008.323, 19114993.
16. Davidson ENB, Vitters EL, van Beuningen HM, Loo FAJ, Berg WB, Kraan PM. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor β-induced osteophytes. Arthritis Rheum 2007, 56:4065-4073. 10.1002/art.23034, 18050218.
17. van der Kraan PM, van den Berg WB. Osteophytes: relevance and biology. Osteoarthritis Cartilage 2007, 15:237-244.
18. Ghosh P. The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Semin Arthritis Rheum 1999, 28:211-267. 10.1016/S0049-0172(99)80021-3, 10073500.
19. Ghosh P, Smith M, Wells C. Second line agents in osteoarthritis. Second Line Agents in the Treatment of Rheumatic Diseases 1991, 363-427. New York: Marcel Dekker, Furst D, Dixon J.
20. Ghosh P, Cheras P. Vascular mechanism in osteoarthritis. Best Pract Res Clin Rheumatol 2001, 15:693-709. 10.1053/berh.2001.0188, 11812016.
21. Andrews JL, Ghosh P, Lentini A, Ternai B. The interaction of pentosan polysulphate (SP54) with human neutrophil elastase and connective tissue matrix components. Chem Biol Interact 1983, 47:157-173. 10.1016/0009-2797(83)90155-2, 6197196.
22. Takizawa M, Yatabe Y, Okada A, Chijiiwa M, Mochizuki S, Ghosh P, Okada Y. Calcium pentosan polysulfate inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes. FEBS Lett 2008, 582:2945-2949. 10.1016/j.febslet.2008.07.036, 18671975.
23. Troeberg L, Fushimi K, Khokha R, Emonard H, Ghosh P, Nagase H. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J 2008, 22:3515-3524.
24. Takizawa M, Ohuchi E, Yamanaka H, Nakamura H, Ikeda E, Ghosh P, Okada Y. Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. Arthritis Rheum 2000, 43:812-820. 10.1002/1529-0131(200004)43:4<812::AID-ANR11>3.0.CO;2-Y, 10765925.
25. Budsberg SC, Bergh MS, Streppa HK. Evaluation of pentosan polysulfate sodium in the postoperative recovery from cranial cruciate injury in dogs: a randomised, placebo-controlled clinical trial. Vet Surg 2007, 36:234-244. 10.1111/j.1532-950X.2007.00256.x, 17461948.
26. Little C, Ghosh P. Potential use of pentosan polysulfate for the treatment of equine joint disease. Joint Disease in the Horse 1996, 281-292. Philadelphia, PA: WB Saunders and Co, McIlwraith CW, Trotter GW.
27. Ghosh P, Edelman J, March L, Smith M. Effects of pentosan polysulfate in osteoarthritis of the knee: a randomized, double blind, placebo-controlled pilot study. Curr Ther Res 2005, 66:552-571.
28. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival and development of human bone marrow stromal stem cells. Blood 2005, 105:3793-3801. 10.1182/blood-2004-11-4349, 15677562.
29. Denker AE, Haas AR, Nicoll SB, Tuan RS. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation 1999, 64:67-76. 10.1046/j.1432-0436.1999.6420067.x, 10234804.
30. Haas AR, Tuan RS. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchemal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function. Differentiation 1999, 64:77-89. 10.1046/j.1432-0436.1999.6420077.x, 10234805.
31. Imabayashi H, Mori T, Gojo S, Kiyono T, Sugiyama T, Irie R, Isogai T, Hata J, Toyami Y, Umezawa A. Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis. Exp Cell Res 2003, 288:35-50. 10.1016/S0014-4827(03)00130-7, 12878157.
32. Kim YJ, Sah RLY, Doong J-YH, Grodzinsky AJ. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 1988, 174:168-176. 10.1016/0003-2697(88)90532-5, 2464289.
33. Gimble J. Marrow stromal adipocytes. Marrow Stromal Cell Culture 1998, 67-87. Cambridge: Cambridge University Press, Beresford JN, Owen ME.
34. Derfoul A, Miyoshi AD, Freeman DE, Tuan RS. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage 2007, 15:646-655. 10.1016/j.joca.2007.01.014, 17337215.
35. Karlsson C, Brantsing C, Svensson T, Brisby H, Asp J, Tallheden T, Lindahl A. Differentiation of human mesenchymal stem cells and articular chondrocytes: analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. J Orthop Res 2007, 25:152-163. 10.1002/jor.20287, 17072841.
36. Li Y, Toole BP, Dealy CN, Kosher RA. Hyaluronan in limb morphogenesis. Dev Biol 2007, 305:411-420. 10.1016/j.ydbio.2007.02.023, 2077829, 17362908.
37. Kavalkovich KW, Boynton RE, Murphy JM, Barry F. Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system. In Vitro Cell Dev Biol Anim 2002, 38:457-466. 10.1290/1071-2690(2002)038<0457:CDOHMS>2.0.CO;2, 12605540.
38. Dvorakova J, Velebny V, Kubala L. Hyaluronan influence on the onset of chondrogenic differentiation of mesenchymal stem cells. Neuro Endocrinol Lett 2008, 29:685-690.
39. San Antonio JD, Winston BM, Tuan RS. Regulation of chondrogenesis by heparan sulfate and structurally related glycosaminoglycans. Dev Biol 1987, 123:17-24. 10.1016/0012-1606(87)90422-2, 2957259.
40. Hadházy C, Módis L, László MB, Kostenszky KS, Zsupán I. Exogenous glycosaminoglycans modulate chondrogenesis, cyclic AMP level and cell growth in limb bud mesenchyme cultures. Tissue Cell 1989, 21:673-685. 10.1016/0040-8166(89)90078-5, 2559493.
41. Nurcombe V, Cool SM. Heparan sulfate control of proliferation and differentiation in the stem cell niche. Crit Rev Eukaryot Gene Expr 2007, 17:159-171.
42. Zehentner BK, Haussmann A, Buetscher H. The bone morphogenetic protein antagonist Noggin is regulated by SOX-9 during endochondral differentiation. Dev Growth Differ 2002, 44:1-9. 10.1046/j.1440-169x.2002.00616.x, 11869287.
43. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 2005, 280:8343-8350. 10.1074/jbc.M413913200, 15623506.
44. Shen B, Shimmon S, Smith MM, Ghosh P. Biosensor analysis of the molecular interactions of pentosan polysulfate and of sulfated glycosaminoglycans with immobilized elastase, hyaluronidase and lysozyme using surface plasmon resonance (SPR) technology. J Pharm Biomed Anal 2003, 31:83-93. 10.1016/S0731-7085(02)00606-4, 12560052.
45. Arai T, Arai A, Busby WH, Clemmons DR. Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5. Endocrinology 1994, 135:2358-2363. 10.1210/en.135.6.2358, 7527332.
46. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimmer K, Chytil A, Horton WA, Moses HL, Spagnoli A. Effect of IFG-1 in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signalling. J Bone Miner Res 2006, 21:626-636. 10.1359/jbmr.051213, 16598383.
47. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J Biol Chem 2000, 275:18574-18580. 10.1074/jbc.M002172200, 10849447.
48. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000, 278:511-515. 10.1006/bbrc.2000.3835, 11095942.
49. Okada A, Mochizuki S, Yatabe T, Kimura T, Shiomi T, Fujita Y, Matsumoto H, Sehara-Fujisawa A, Iwamoto Y, Okada Y. ADAM-12 (Meltrin ∂) is involved in chondrocyte proliferation via cleavage of insulin-like growth factor binding protein 5 in osteoarthritic cartilage. Arthritis Rheum 2008, 58:778-789. 10.1002/art.23262, 18311789.
50. Grogen SP, Miyaki S, Asahara H, D'Lima DD, Lotz MK. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther 2009, 11:R85. 10.1186/ar2719, 2714136, 19500336.
51. Sorensen HP, Vives RR, Manetopoulos C, Albrechtsen R, Lydolph MC, Jacobsen J, Couchman JR, Wewer UM. Heparan sulfate regulates ADAM 12 through a molecular switch mechanism. J Biol Chem 2008, 283:31920-31932. 10.1074/jbc.M804113200, 18801731.
52. O'Rear L, Longobardi L, Torello M, Law BK, Moses HL, Chiarelli F, Spagnoli A. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-β in mesenchymal chondroprogenitor cell growth. J Mol Endocrinol 2005, 34:723-737. 10.1677/jme.1.01746, 15956343.